Aug 9, 2024· Comment from Consumer Healthcare Products Association· FDA-2024-N-2422-0003
Comments from the Consumer Healthcare Products Association (CHPA)
FDANonrulemakingFDA-2024-N-2422
Amending Over-the-Counter Monograph M013: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use
RIN
—
Last modified
Oct 1, 2024
Comment window
closed 669d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Aug 9, 2024 and Aug 9, 2024. 0 other organizations filed here. The comment window closed 669d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%